Troponin I Surveillance to Risk-Stratify Early Events After Immune Checkpoint Inhibitor Initiation
Background: Troponin surveillance may facilitate early detection of immune checkpoint inhibitor (ICI)-associated myocarditis, but mild elevations and baseline abnormalities complicate interpretation. We assessed early post-ICI troponin I (TnI) dynamics and the performance characteristics of clinically applicable peak TnI thresholds within 3 months of ICI initiation.
Authors
- Yudai Tamura (ORCID: https://orcid.org/0000-0002-5596-8436)
- Masao Daimon (ORCID: https://orcid.org/0000-0002-7616-3477)
- Sarasa Isobe (ORCID: https://orcid.org/0000-0002-7405-0903)
- Issei Komuro (ORCID: https://orcid.org/0000-0002-0714-7182)
- Hiroyuki Fujii (ORCID: https://orcid.org/0000-0002-8998-3693)
- Masahiko Goya (ORCID: https://orcid.org/0000-0002-7210-0671)
- Jin Iwasawa (ORCID: https://orcid.org/0000-0003-4585-124X)
- Yuichi Tamura (ORCID: https://orcid.org/0000-0002-4437-8019)
- Shinsuke Aida (ORCID: https://orcid.org/0000-0002-8907-3104)
- Yukihiro Yamaguchi (ORCID: https://orcid.org/0000-0003-3988-2912)
- Shigeki Kimura (ORCID: https://orcid.org/0000-0002-8572-6649)
Institutions
- Mita Hospital (JP)
- International University of Health and Welfare (JP)
Publication Details
- Journal
- Circulation Reports
- Published
- 2026-09-14
- DOI
- https://doi.org/10.1253/circrep.cr-26-0251
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00